Remote results of pathogenetic therapy of cystic breast disease
https://doi.org/10.17650/1994-4098-2014-0-4-35-36
Abstract
With 2000 year of pathogenetic treatment of fibrocystic breast disease preventing cystadenocarcinoma has led to positive results. In 2000–2001 years the percentage devoted to oncological indications for surgical treatment of patients with fibrocystic disease of the breast, was less than 3 % of the total number of operated on for various diseases of the breast.
About the Authors
G. Kh. Khanafiev
City Clinical Hospital Forty, Yekaterinburg
Russian Federation
Russian Federation
S. A. Berzin
Department of Oncology and Medical Radiology, Ural State Medical Academy, Ministry of Health of Russia, Yekaterinburg
Russian Federation
Russian Federation
S. M. Demidov
Department of Oncology and Medical Radiology, Ural State Medical Academy,
Ministry of Health of Russia, Yekaterinburg
Russian Federation
Russian Federation
References
1. Сидоренко Л.Н. Мастопатия. Л.: Медицина, 1991.
2. Столл Б.А. Эндокринная система и рак молочной железы. М.: Медицина, 1984. 312 с.
3. Чумаченко П.А. Молочная железа и эндокринный гомеостаз. Воронеж, 1987. С. 72–120.
4. Zonderland H.M., Hermans J., Holscher H.C. Additional value of USmammography profit and loss. Radiology 1994;4(6):511–6.
5. Ханафиев Г.Х., Берзин С.А., Демидов С.М., Зотова И.Б. Содержание гормонов в кистах молочных желез. Высокие технологии в онкологии: Материалы V Всероссийского съезда онкологов. Казань, 2000. С. 110–2.
6. Ханафиев Г.Х., Берзин С.А., Демидов С.М., Бушуева Т.В. Кистозная болезнь молочных желез. Екатеринбург, 2002
Review
For citations:
Khanafiev G.Kh., Berzin S.A., Demidov S.M. Remote results of pathogenetic therapy of cystic breast disease. Tumors of female reproductive system. 2014;(4):35-36. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-4-35-36
Views:
693
Email this article 